FULCRUM THERAPEUTICS INC's ticker is FULC and the CUSIP is 359616109. A total of 68 filers reported holding FULCRUM THERAPEUTICS INC in Q2 2021. The put-call ratio across all filers is - and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $154,752 | -57.8% | 54,299 | +7.9% | 0.00% | -100.0% |
| Q4 2022 | $366,359 | -1.5% | 50,324 | +9.3% | 0.00% | 0.0% |
| Q3 2022 | $372,000 | +106.7% | 46,031 | +25.4% | 0.00% | – |
| Q2 2022 | $180,000 | -78.0% | 36,701 | +5.9% | 0.00% | -100.0% |
| Q1 2022 | $819,000 | +26.2% | 34,642 | -5.6% | 0.00% | 0.0% |
| Q4 2021 | $649,000 | +59.9% | 36,704 | +155.0% | 0.00% | 0.0% |
| Q3 2021 | $406,000 | +26.9% | 14,396 | -52.9% | 0.00% | – |
| Q2 2021 | $320,000 | +5.6% | 30,559 | +19.0% | 0.00% | – |
| Q1 2021 | $303,000 | +13.9% | 25,687 | +13.2% | 0.00% | – |
| Q4 2020 | $266,000 | +58.3% | 22,701 | +7.2% | 0.00% | – |
| Q3 2020 | $168,000 | -52.1% | 21,171 | +10.2% | 0.00% | -100.0% |
| Q2 2020 | $351,000 | +53.3% | 19,209 | 0.0% | 0.00% | – |
| Q1 2020 | $229,000 | +99.1% | 19,209 | +178.5% | 0.00% | – |
| Q4 2019 | $115,000 | +144.7% | 6,897 | -2.5% | 0.00% | – |
| Q3 2019 | $47,000 | – | 7,074 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TRV GP IV, LLC | 2,343,154 | $10,403,604 | 3.92% |
| SUVRETTA CAPITAL MANAGEMENT, LLC | 5,718,881 | $25,391,832 | 1.37% |
| COWEN AND COMPANY, LLC | 4,308,359 | $19,129,113 | 1.34% |
| RA Capital Management | 11,609,704 | $51,547,086 | 1.02% |
| RTW INVESTMENTS, LP | 5,818,804 | $25,835,490 | 0.54% |
| Acuitas Investments, LLC | 134,811 | $598,561 | 0.35% |
| Simplify Asset Management Inc. | 570,519 | $2,533,104 | 0.29% |
| Vivo Capital, LLC | 520,000 | $2,308,800 | 0.25% |
| BRANDYWINE MANAGERS, LLC | 26,127 | $116,004 | 0.20% |
| DENALI ADVISORS LLC | 70,600 | $313,464 | 0.11% |